Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5

Artif DNA PNA XNA. 2013 Apr-Jun;4(2):49-57. doi: 10.4161/adna.25628.

Abstract

The development of a new class of peptide nucleic acids (PNAs), i.e., gamma PNAs (γPNAs), creates the need for a general and effective method for its delivery into cells for regulating gene expression in mammalian cells. Here we report the antisense activity of a recently developed hydrophilic and biocompatible diethylene glycol (miniPEG)-based gamma peptide nucleic acid called MPγPNAs via its delivery by poly(lactide-co-glycolide) (PLGA)-based nanoparticle system. We show that MPγPNA oligomers designed to bind to the selective region of chemokine receptor 5 (CC R5) transcript, induce potent and sequence-specific antisense effects as compared with regular PNA oligomers. In addition, PLGA nanoparticle delivery of MPγPNAs is not toxic to the cells. The findings reported in this study provide a combination of γPNA technology and PLGA-based nanoparticle delivery method for regulating gene expression in live cells via the antisense mechanism.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Base Sequence
  • Gene Expression
  • Gene Knockdown Techniques
  • Gene Silencing
  • HeLa Cells
  • Humans
  • Kinetics
  • Nanocapsules / chemistry*
  • Oligonucleotides, Antisense / chemistry
  • Oligonucleotides, Antisense / genetics
  • Particle Size
  • Peptide Nucleic Acids / chemistry
  • Peptide Nucleic Acids / genetics*
  • Receptors, CCR5 / genetics
  • Receptors, CCR5 / metabolism
  • Transfection / methods

Substances

  • CCR5 protein, human
  • Nanocapsules
  • Oligonucleotides, Antisense
  • Peptide Nucleic Acids
  • Receptors, CCR5